Companies /Healthcare

Annovis Bio Inc

NYSE: ANVS Biotechnology
$1.78
▼ $0.04 (−2.20%) today
Markets closed · 2:07am ET
Today · % change

Fundamentals

Market Cap
$77.5M
EPS (TTM)
$-1.82
52-Week Range
$2 – $6
Street Target
$11.00

About Annovis Bio

Annovis Bio, Inc., a clinical-stage drug platform company, develops drugs to treat neurodegeneration. The company is headquartered in Berwyn, Pennsylvania.

ANVS Coverage